Evidence of sex differences in cellular senescence
Open accessThe DOI matches its Crossref record; 74 of the 74 references it cites were found in a registry or an index.
Abstract
Biological sex is a factor in many conditions, including aging, neurodegenerative disease, cancer, and more. For each of these, men and women display distinct differences in disease development and progression. To date, studies on the molecular basis of such differences have largely focused on sex hormones, typically highlighting their neuroprotective benefits. However, new research suggests that cellular senescence may underlie sex differences in both neurological and non-neurological pathologies. Cellular senescence-stable proliferative arrest with a unique pro-inflammatory phenotype-occurs in response to persistent DNA damage signaling, safeguarding against tissue-level consequences of DNA damage (e.g., tumorigenesis). Though critical for maintaining tissue health, senescence has also been implicated in disease. Indeed, senescent cell accumulation occurs in multiple disease contexts, and the elimination of such cells (via senolytic therapies) alleviates associated disease hallmarks. If cell senescence is a driver of pathophysiology, sex differences in cellular senescence may underlie sex-specific disease outcomes. This review summarizes evidence of sex differences in cellular senescence-highlighting findings from both human and animal studies-and briefly discusses the potential relevance of sex chromosome epigenetics and mosaicism. Current studies show that female sex is associated with greater susceptibility to DNA damage and greater likelihood of senescence onset, despite additional evidence that estrogen protects against genotoxic insult and inhibits senescence regulatory proteins. Further studies on sex differences in cellular senescence are needed, both to verify whether findings from animal studies hold true in human contexts and to validate whether senescence manifests differently between men and women following comparable senescence-inducing stimuli.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218
Cellular senescence: when bad things happen to good cells
Campisi, J., & d'Adda di Fagagna, F. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2233 · Cited by 4,441
The DNA Damage Response: Making It Safe to Play with Knives
Ciccia, A., & Elledge, S. J. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.09.019 · Cited by 4,368 · cited 1×
“chromatin stability and support the recruitment of other DDR factors (Ciccia and Elledge, 2010; d’Adda di Fagagna, 2008).”
Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty
Ferrucci, L., & Fabbri, E. (2018) · Nature Reviews Cardiology · doi:10.1038/s41569-018-0064-2 · Cited by 3,690 · cited 1×
“, 2018), anxiety and mood disorders (Diniz, 2018; Ferrucci and Fabbri, 2018; Ogrodnik et al., 2019), cancer (Kuilman et al.”
Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders
Baker, D. J., Wijshake, T., Tchkonia, T., LeBrasseur, N. K., Childs, B. G., van de Sluis, B., Kirkland, J. L., & van Deursen, J. M. (2011) · Nature · doi:10.1038/nature10600 · Cited by 3,670 · cited 1×
“evidence that the chronic presence of senescent cells contributes to disease in later stages of life or following injury (Baker et al., 2011; Guerrero et al., 2021; Salminen et al., 2011; Schwab et al., 2021).”
InfluentialAgeing as a risk factor for neurodegenerative disease
Hou, Y., Dan, X., Babbar, M., Wei, Y., Hasselbalch, S. G., Croteau, D. L., & Bohr, V. A. (2019) · Nature Reviews Neurology · doi:10.1038/s41582-019-0244-7 · Cited by 3,310
Oxidative DNA damage: mechanisms, mutation, and disease
Cooke, M. S., Evans, M. D., Dizdaroglu, M., & Lunec, J. (2003) · The FASEB Journal · doi:10.1096/fj.02-0752rev · Cited by 3,245 · cited 1×
“Firstly, estrogen can reduce oxidative stress, a known cause of SSBs and replication stress (Cooke et al., 2003; Venkatachalam et al., 2017).”
Naturally occurring p16Ink4a-positive cells shorten healthy lifespan
Baker, D. J., Childs, B. G., Durik, M., Wijers, M. E., Sieben, C. J., Zhong, J., A. Saltness, R., Jeganathan, K. B., Verzosa, G. C., Pezeshki, A., et al. (2016) · Nature · doi:10.1038/nature16932 · Cited by 2,876 · cited 2×
“In ageing and progeroid mice, elimination of senescent cells increases lifespan (Baker et al., 2016), reduces age-related tissue deterioration (Baker et al.”
Sensing DNA Damage Through ATRIP Recognition of RPA-ssDNA Complexes
Zou, L., & Elledge, S. J. (2003) · Science · doi:10.1126/science.1083430 · Cited by 2,693
McLean, C. P., Asnaani, A., Litz, B. T., & Hofmann, S. G. (2011) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2011.03.006 · Cited by 2,519
Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas
Xue, W., Zender, L., Miething, C., Dickins, R. A., Hernando, E., Krizhanovsky, V., Cordon-Cardo, C., & Lowe, S. W. (2007) · Nature · doi:10.1038/nature05529 · Cited by 2,473 · cited 1×
“Further, by secreting pro-inflammatory factors, senescent cells recruit the immune system to facilitate their own elimination and subsequent replacement with progenitor cells (Colafella and Denton, 2018; Guerrero et al., 2021; Xue et al., 2007), thereby safeguarding against tumorigenesis.”
Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors
Campisi, J. (2005) · Cell · doi:10.1016/j.cell.2005.02.003 · Cited by 2,379 · cited 2×
“As such, some authors suggest that cellular senescence is ultimately antagonistically pleiotropic (Campisi, 2005; Chinta et al., 2018), offering protective benefits in earlier stages of life but generating problems later on as senescent cells accumulate and give rise to a chronic, SASP-driven…”
A complex secretory program orchestrated by the inflammasome controls paracrine senescence
Acosta, J. C., Banito, A., Wuestefeld, T., Georgilis, A., Janich, P., Morton, J. P., Athineos, D., Kang, T.-W., Lasitschka, F., Andrulis, M., et al. (2013) · Nature Cell Biology · doi:10.1038/ncb2784 · Cited by 2,278
Cellular senescence in ageing: from mechanisms to therapeutic opportunities
Di Micco, R., Krizhanovsky, V., Baker, D., & d’Adda di Fagagna, F. (2021) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-020-00314-w · Cited by 2,277
Persistent DNA damage signalling triggers senescence-associated inflammatory cytokine secretion
Rodier, F., Coppé, J.-P., Patil, C. K., Hoeijmakers, W. A. M., Muñoz, D. P., Raza, S. R., Freund, A., Campeau, E., Davalos, A. R., & Campisi, J. (2009) · Nature Cell Biology · doi:10.1038/ncb1909 · Cited by 2,232
Mechanisms of DNA damage, repair, and mutagenesis
Chatterjee, N., & Walker, G. C. (2017) · Environmental and Molecular Mutagenesis · doi:10.1002/em.22087 · Cited by 2,039 · cited 3×
“initiates DDR signaling directly (Chatterjee and Walker, 2017), oncogene activation leads to DNA hyperreplication and subsequent replication stress (Di Micco et al.”
The essence of senescence: Figure 1.
Kuilman, T., Michaloglou, C., Mooi, W. J., & Peeper, D. S. (2010) · Genes & Development · doi:10.1101/gad.1971610 · Cited by 2,038
Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication
Di Micco, R., Fumagalli, M., Cicalese, A., Piccinin, S., Gasparini, P., Luise, C., Schurra, C., Garre’, M., Giovanni Nuciforo, P., Bensimon, A., et al. (2006) · Nature · doi:10.1038/nature05327 · Cited by 1,821 · cited 1×
“…initiates DDR signaling directly (Chatterjee and Walker, 2017), oncogene activation leads to DNA hyperreplication and subsequent replication stress (Di Micco et al., 2021, 2006), and oxidative stress produces replication stress as well as single-strand breaks (SSBs) (Venkatachalam et al., 2017).”
Why is depression more prevalent in women?
Albert, P. R. (2015) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.150205 · Cited by 1,785 · cited 4×
“, 2015), greater likelihood of being diagnosed with depression (Albert, 2015) and greater likelihood of experiencing worse post-mTBI symptoms (Bazarian et al.”
InfluentialMechanisms of Cellular Senescence: Cell Cycle Arrest and Senescence Associated Secretory Phenotype
Kumari, R., & Jat, P. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.645593 · Cited by 1,622 · cited 18×
“…p16-pRB is slower to become active, functioning to prolong and maintain this state of arrest (Alcorta et al., 1996; Ben-Porath and Weinberg, 2005; Kumari and Jat, 2021) while also serving as a second barrier to cell cycle re-entry should p53-p21 fail (Beauséjour et al., 2003; Mikuła-Pietrasik et…”
InfluentialRole of the INK4a Locus in Tumor Suppression and Cell Mortality
Serrano, M., Lee, H.-W., Chin, L., Cordon-Cardo, C., Beach, D., & DePinho, R. A. (1996) · Cell · doi:10.1016/s0092-8674(00)81079-x · Cited by 1,585 · cited 1×
“…Mikuła-Pietrasik et al., 2020), oncogene activation (Bartek et al., 2007; Carroll and Korolchuk, 2018; Di Micco et al., 2021; Kuilman et al., 2010; Serrano et al., 1997), and genotoxic stressors like oxidative stress, ionizing radiation, ultraviolet radiation, and exogenous chemical agents…”
γH2AX: a sensitive molecular marker of DNA damage and repair
Mah, L.-J., El-Osta, A., & Karagiannis, T. C. (2010) · Leukemia · doi:10.1038/leu.2010.6 · Cited by 1,557
Seedat, S., Scott, K. M., Angermeyer, M. C., Berglund, P., Bromet, E. J., Brugha, T. S., Demyttenaere, K., de Girolamo, G., Haro, J. M., Jin, R., et al. (2009) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2009.36 · Cited by 1,518
Reversal of human cellular senescence: roles of the p53 and p16 pathways
Beauséjour, C. M., Krtolica, A., Galimi, F., Narita, M., Lowe, S. W., Yaswen, P., & Campisi, J. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg417 · Cited by 1,457
Clearance of senescent glial cells prevents tau-dependent pathology and cognitive decline
Bussian, T. J., Aziz, A., Meyer, C. F., Swenson, B. L., van Deursen, J. M., & Baker, D. J. (2018) · Nature · doi:10.1038/s41586-018-0543-y · Cited by 1,289 · cited 1×
“, 2021), neurodegenerative disease (Bussian et al., 2018; Chinta et al., 2018; Guerrero et al., 2021; Hou et al., 2019; Musi et al., 2018), anxiety and mood disorders (Diniz, 2018; Ferrucci and Fabbri, 2018; Ogrodnik et al.”
Senolytic drugs: from discovery to translation
Kirkland, J. L., & Tchkonia, T. (2020) · Journal of Internal Medicine · doi:10.1111/joim.13141 · Cited by 1,227
Living on a break: cellular senescence as a DNA-damage response
d'Adda di Fagagna, F. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2440 · Cited by 1,170
Laberge, R.-M., Sun, Y., Orjalo, A. V., Patil, C. K., Freund, A., Zhou, L., Curran, S. C., Davalos, A. R., Wilson-Edell, K. A., Liu, S., et al. (2015) · Nature Cell Biology · doi:10.1038/ncb3195 · Cited by 1,160 · cited 1×
“, 2013), mTOR (Herranz et al., 2015; Laberge et al., 2015), macroH2A1 and ATM (Chen et al.”
Oxygen sensitivity severely limits the replicative lifespan of murine fibroblasts
Parrinello, S., Samper, E., Krtolica, A., Goldstein, J., Melov, S., & Campisi, J. (2003) · Nature Cell Biology · doi:10.1038/ncb1024 · Cited by 1,116
The signals and pathways activating cellular senescence
Ben-Porath, I., & Weinberg, R. A. (2005) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2004.10.013 · Cited by 1,046 · cited 1×
“of arrest (Alcorta et al., 1996; Ben-Porath and Weinberg, 2005; Kumari and Jat, 2021) while also serving as a second barrier to cell cycle re-entry should p53-p21 fail (Beauséjour et al.”
Cellular senescence drives age-dependent hepatic steatosis
Ogrodnik, M., Miwa, S., Tchkonia, T., Tiniakos, D., Wilson, C. L., Lahat, A., Day, C. P., Burt, A., Palmer, A., Anstee, Q. M., et al. (2017) · Nature Communications · doi:10.1038/ncomms15691 · Cited by 1,044
Freund, A., Patil, C. K., & Campisi, J. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.69 · Cited by 1,039 · cited 1×
“These pathways include (but are not limited to): p38MAPK (Freund et al., 2011), JAK2/STAT3 (Xu et al.”
Alcorta, D. A., Xiong, Y., Phelps, D., Hannon, G., Beach, D., & Barrett, J. C. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.24.13742 · Cited by 1,008
Xu, M., Tchkonia, T., Ding, H., Ogrodnik, M., Lubbers, E. R., Pirtskhalava, T., White, T. A., Johnson, K. O., Stout, M. B., Mezera, V., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1515386112 · Cited by 915 · cited 3×
“These pathways include (but are not limited to): p38MAPK (Freund et al., 2011), JAK2/STAT3 (Xu et al., 2015), inflammasome (Acosta et al., 2013), mTOR (Herranz et al., 2015; Laberge et al., 2015), macroH2A1 and ATM (Chen et al., 2015), and PI3K (Zhang et al., 2018), which have all been separately implicated in SASP re…”
Mitochondria are required for pro-ageing features of the senescent phenotype
Correia‐Melo, C., Marques, F. D., Anderson, R., Hewitt, G., Hewitt, R., Cole, J., Carroll, B. M., Miwa, S., Birch, J., Merz, A., et al. (2016) · The EMBO Journal · doi:10.15252/embj.201592862 · Cited by 796
mTOR regulates MAPKAPK2 translation to control the senescence-associated secretory phenotype
Herranz, N., Gallage, S., Mellone, M., Wuestefeld, T., Klotz, S., Hanley, C. J., Raguz, S., Acosta, J. C., Innes, A. J., Banito, A., et al. (2015) · Nature Cell Biology · doi:10.1038/ncb3225 · Cited by 788
Roos, C. M., Zhang, B., Palmer, A. K., Ogrodnik, M. B., Pirtskhalava, T., Thalji, N. M., Hagler, M., Jurk, D., Smith, L. A., Casaclang‐Verzosa, G., et al. (2016) · Aging Cell · doi:10.1111/acel.12458 · Cited by 738
Sex Differences in the Clinical Manifestations of Alzheimer Disease Pathology
Barnes, L. L., Wilson, R. S., Bienias, J. L., Schneider, J. A., Evans, D. A., & Bennett, D. A. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.6.685 · Cited by 643
Tau protein aggregation is associated with cellular senescence in the brain
Musi, N., Valentine, J. M., Sickora, K. R., Baeuerle, E., Thompson, C. S., Shen, Q., & Orr, M. E. (2018) · Aging Cell · doi:10.1111/acel.12840 · Cited by 595 · cited 2×
“, 2021), neurodegenerative disease (Bussian et al., 2018; Chinta et al., 2018; Guerrero et al., 2021; Hou et al., 2019; Musi et al., 2018), anxiety and mood disorders (Diniz, 2018; Ferrucci and Fabbri, 2018; Ogrodnik et al.”
Astrocyte Senescence as a Component of Alzheimer’s Disease
Bhat, R., Crowe, E. P., Bitto, A., Moh, M., Katsetos, C. D., Garcia, F. U., Johnson, F. B., Trojanowski, J. Q., Sell, C., & Torres, C. (2012) · PLoS ONE · doi:10.1371/journal.pone.0045069 · Cited by 586
Obesity-Induced Cellular Senescence Drives Anxiety and Impairs Neurogenesis
Ogrodnik, M., Zhu, Y., Langhi, L. G. P., Tchkonia, T., Krüger, P., Fielder, E., Victorelli, S., Ruswhandi, R. A., Giorgadze, N., Pirtskhalava, T., et al. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2018.12.008 · Cited by 536
Sex Differences in Traumatic Brain Injury: What We Know and What We Should Know
Gupte, R. P., Brooks, W. M., Vukas, R. R., Pierce, J. D., & Harris, J. L. (2019) · Journal of Neurotrauma · doi:10.1089/neu.2018.6171 · Cited by 533
Chinta, S. J., Woods, G., Demaria, M., Rane, A., Zou, Y., McQuade, A., Rajagopalan, S., Limbad, C., Madden, D. T., Campisi, J., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2017.12.092 · Cited by 530 · cited 2×
“, 2021), neurodegenerative disease (Bussian et al., 2018; Chinta et al., 2018; Guerrero et al., 2021; Hou et al., 2019; Musi et al., 2018), anxiety and mood disorders (Diniz, 2018; Ferrucci and Fabbri, 2018; Ogrodnik et al.”
DNA damage signalling guards against activated oncogenes and tumour progression
Bartek, J., Bartkova, J., & Lukas, J. (2007) · Oncogene · doi:10.1038/sj.onc.1210881 · Cited by 521
Sex differences in biological aging with a focus on human studies
Hägg, S., & Jylhävä, J. (2021) · eLife · doi:10.7554/elife.63425 · Cited by 442 · cited 2×
“This is true for ageing and age-related frailty (Colafella and Denton, 2018; Fischer and Riddle, 2018; Hägg and Jylhävä, 2021), neurodegenerative conditions like Alzheimer’s Disease (AD) (Ardekani et al., 2016; Barnes et al., 2005; Takizawa et al., 2015) and Parkinson’s Disease (PD) (McLean et al.,…”
Opposing roles for p16Ink4a and p19Arf in senescence and ageing caused by BubR1 insufficiency
Baker, D. J., Perez-Terzic, C., Jin, F., Pitel, K. S., Niederländer, N. J., Jeganathan, K., Yamada, S., Reyes, S., Rowe, L., Hiddinga, H. J., et al. (2008) · Nature Cell Biology · doi:10.1038/ncb1744 · Cited by 408
Changes in DNA repair during aging
Gorbunova, V., Seluanov, A., Mao, Z., & Hine, C. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm756 · Cited by 405
Gender differences in Parkinson's disease: Clinical characteristics and cognition
Miller, I. N., & Cronin‐Golomb, A. (2010) · Movement Disorders · doi:10.1002/mds.23388 · Cited by 405 · cited 1×
“, 2015) and Parkinson’s Disease (PD) (McLean et al., 2011; Miller and Cronin-Golomb, 2010; Wooten et al., 2004), anxiety and mood disorders (Albert, 2015; Bekker and van Mens-Verhulst, 2007; Dahodwala et al.”
Bekker, M. H. J., & van Mens-Verhulst, J. (2007) · Gender Medicine · doi:10.1016/s1550-8579(07)80057-x · Cited by 362
Salminen, A., Ojala, J., Kaarniranta, K., Haapasalo, A., Hiltunen, M., & Soininen, H. (2011) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2011.07738.x · Cited by 333 · cited 2×
“Evidence of senescent cell accumulation has been found for multiple diseases, including aging and progeria (Baker et al., 2016, 2011, 2008; Salminen et al., 2011; Wang et al., 2021), neurodegenerative disease (Bussian et al.”
InfluentialTissue specificity of senescent cell accumulation during physiologic and accelerated aging of mice
Yousefzadeh, M. J., Zhao, J., Bukata, C., Wade, E. A., McGowan, S. J., Angelini, L. A., Bank, M. P., Gurkar, A. U., McGuckian, C. A., Calubag, M. F., et al. (2020) · Aging Cell · doi:10.1111/acel.13094 · Cited by 331 · cited 2×
“1, in the context of sex differences in the cellular response to DNA damage (Kfoury et al., 2018; Malorni et al., 2008; Sun et al., 2014; Yousefzadeh et al., 2020).”
Mitochondrial dysfunction and cell senescence: deciphering a complex relationship
Chapman, J., Fielder, E., & Passos, J. F. (2019) · FEBS Letters · doi:10.1002/1873-3468.13498 · Cited by 325 · cited 4×
“These changes include increased mitochondrial biogenesis, changes in mitochondrial fusion and fission (in favour of fusion), and reduced mitochondrial autophagy (or mitophagy) (Chapman et al., 2019).”
InfluentialClearance of senescent decidual cells by uterine natural killer cells in cycling human endometrium
Brighton, P. J., Maruyama, Y., Fishwick, K., Vrljicak, P., Tewary, S., Fujihara, R., Muter, J., Lucas, E. S., Yamada, T., Woods, L., et al. (2017) · eLife · doi:10.7554/elife.31274 · Cited by 323
McConnell, B. B., Starborg, M., Brookes, S., & Peters, G. (1998) · Current Biology · doi:10.1016/s0960-9822(98)70137-x · Cited by 314 · cited 1×
“The upregulation of p16 occurs parallel to (but independently of) p53-p21 pathway activation, in response to cellular stress and by unknown means (Liu et al., 2019; McConnell et al., 1998; Palmero et al., 1997; Serrano et al., 1996).”
The choice between p53-induced senescence and quiescence is determined in part by the mTOR pathway.
Korotchkina, L. G., Leontieva, O. V., Bukreeva, E. I., Demidenko, Z. N., Gudkov, A. V., & Blagosklonny, M. V. (2010) · Aging · doi:10.18632/aging.100160 · Cited by 278
Stracker, T. H., Theunissen, J.-W. F., Morales, M., & Petrini, J. H. J. (2004) · DNA Repair · doi:10.1016/j.dnarep.2004.03.014 · Cited by 263
Crosstalk between chromatin state and DNA damage response in cellular senescence and cancer.
Sulli, G., Di Micco, R., & di Fagagna, F. D. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3344 · Cited by 238
Cellular senescence at the crossroads of inflammation and Alzheimer's disease
Guerrero, A., De Strooper, B., & Arancibia-Cárcamo, I. L. (2021) · Trends in Neurosciences · doi:10.1016/j.tins.2021.06.007 · Cited by 236 · cited 7×
“, 2021), neurodegenerative disease (Bussian et al., 2018; Chinta et al., 2018; Guerrero et al., 2021; Hou et al., 2019; Musi et al., 2018), anxiety and mood disorders (Diniz, 2018; Ferrucci and Fabbri, 2018; Ogrodnik et al.”
InfluentialSecomandi, L., Borghesan, M., Velarde, M., & Demaria, M. (2022) · Human Reproduction Update · doi:10.1093/humupd/dmab038 · Cited by 208
Chen, H., Ruiz, P. D., McKimpson, W. M., Novikov, L., Kitsis, R. N., & Gamble, M. J. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.07.011 · Cited by 205
Pazolli, E., Alspach, E., Milczarek, A., Prior, J., Piwnica-Worms, D., & Stewart, S. A. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-3386 · Cited by 192 · cited 2×
“To name a few, this includes H2AX, which, when phosphorylated into γH2AX—a common marker of DSB formation and DDR activation (Bielak-Zmijewska et al., 2018; Ksiazek et al., 2009; Pazolli et al., 2012; Venkatachalam et al., 2017)—recruits additional ATM complexes (Kumari and”
Astrocyte senescence promotes glutamate toxicity in cortical neurons
Limbad, C., Oron, T. R., Alimirah, F., Davalos, A. R., Tracy, T. E., Gan, L., Desprez, P.-Y., & Campisi, J. (2020) · PLOS ONE · doi:10.1371/journal.pone.0227887 · Cited by 183
Torres, M. J., Kew, K. A., Ryan, T. E., Pennington, E. R., Lin, C.-T., Buddo, K. A., Fix, A. M., Smith, C. A., Gilliam, L. A., Karvinen, S., et al. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2017.10.003 · Cited by 170 · cited 1×
“By directly interacting with mitochondria (Torres et al., 2018) or by activating mitochondrial estrogen receptors (ERs) (Lejri et al.”
Mitochondrial Effects of Estrogen Are Mediated by Estrogen Receptor α in Brain Endothelial Cells
Razmara, A., Sunday, L., Stirone, C., Wang, X. B., Krause, D. N., Duckles, S. P., & Procaccio, V. (2008) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.134072 · Cited by 161 · cited 1×
“, 2018) or by activating mitochondrial estrogen receptors (ERs) (Lejri et al., 2018; Razmara et al., 2008), estrogen can suppress the release of reactive oxygen species (ROS), thereby preventing ROS-induced DNA damage.”
Senescent fibroblasts resist apoptosis by downregulating caspase-3.
Marcotte, R., Lacelle, C., & Wang, E. (2004) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2004.07.007 · Cited by 159 · cited 1×
“…fact that these responses are so distinct—with senescent cells actively resisting both apoptosis (e.g., by downregulating pro-apoptotic caspase-3) (Marcotte et al., 2004) and excessive cell proliferation—suggests that intrinsic cellular characteristics (e.g., biological sex) influence cell fate.”
Zhang, B., Fu, D., Xu, Q., Cong, X., Wu, C., Zhong, X., Ma, Y., Lv, Z., Chen, F., Han, L., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-04010-4 · Cited by 157
He, N., Jin, W.-L., Lok, K.-H., Wang, Y., Yin, M., & Wang, Z.-J. (2013) · Cell Death & Disease · doi:10.1038/cddis.2013.437 · Cited by 151
Analysis of the MIRIAD Data Shows Sex Differences in Hippocampal Atrophy Progression
Ardekani, B. A., Convit, A., & Bachman, A. H. (2016) · Journal of Alzheimer's Disease · doi:10.3233/jad-150780 · Cited by 141
ROSELLI, C. E. (1991) · Endocrinology · doi:10.1210/endo-128-3-1310 · Cited by 139 · cited 1×
“In support of this prediction are findings from one group that found that the administration of testosterone in gonadectomised rats had greater stimulatory effects on aromatase in male brains than female ones (Roselli, 1991).”
The DNA Damage Response in Neurons: Die by Apoptosis or Survive in a Senescence-Like State?
Fielder, E., von Zglinicki, T., & Jurk, D. (2017) · Journal of Alzheimer's Disease · doi:10.3233/jad-161221 · Cited by 126
Are there roles for brain cell senescence in aging and neurodegenerative disorders?
Tan, F. C. C., Hutchison, E. R., Eitan, E., & Mattson, M. P. (2014) · Biogerontology · doi:10.1007/s10522-014-9532-1 · Cited by 116
Tominaga, T., Shimada, R., Okada, Y., Kawamata, T., & Kibayashi, K. (2019) · PLOS ONE · doi:10.1371/journal.pone.0213673 · Cited by 66 · cited 2×
“, 2019), as well as in mice models of mTBI (Tominaga et al., 2019), senescence markers are significantly increased compared to non-injured controls.”
DNA repair deficiency and senescence in concussed professional athletes involved in contact sports
Schwab, N., Grenier, K., & Hazrati, L.-N. (2019) · Acta Neuropathologica Communications · doi:10.1186/s40478-019-0822-3 · Cited by 47
Self-citationSong, X., Aw, J. T. M., Ma, F., Cheung, M. F., Leung, D., & Herrup, K. (2021) · The Journal of Neuroscience · doi:10.1523/jneurosci.0845-21.2021 · Cited by 23
Cited by
Mechanisms of sex differences in Alzheimer’s disease
Lopez-Lee, C., Torres, E. R. S., Carling, G., & Gan, L. (2024) · Neuron · doi:10.1016/j.neuron.2024.01.024 · Cited by 376
“69 Moreover, the Tert gene,which programstelomerase,containsanestrogen receptor element, enabling estradiol to protect against telomere shortening.”
Emerging insights in senescence: pathways from preclinical models to therapeutic innovations
Mansfield, L., Ramponi, V., Gupta, K., Stevenson, T., Mathew, A. B., Barinda, A. J., Herbstein, F., & Morsli, S. (2024) · npj Aging · doi:10.1038/s41514-024-00181-1 · Cited by 88
The potency of mesenchymal stem/stromal cells: does donor sex matter?
Maged, G., Abdelsamed, M. A., Wang, H., & Lotfy, A. (2024) · Stem Cell Research & Therapy · doi:10.1186/s13287-024-03722-3 · Cited by 42
“The sex differences in cellular senescence have been reported in many other cell types and the causes are not clear yet; however, some factors such as sex chromosomes may play a role [58].”
BackgroundFailure of senolytic treatment to prevent cognitive decline in a female rodent model of aging
Rani, A., Bean, L., Budamagunta, V., Kumar, A., & Foster, T. C. (2024) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2024.1384554 · Cited by 16
Olinger, B., Anerillas, C., Herman, A. B., Tsitsipatis, D., Banarjee, R., Tanaka, T., Candia, J., Maragkakis, M., Bandinelli, S., Walker, K. A., et al. (2026) · doi:10.64898/2026.02.06.26345739
Metadata
- Authors
- Ng, M., & Hazrati, L.-N.
- Venue
- Neurobiology of Aging
- Publisher
- Elsevier BV
- Published
- 2022-12
- Volume
- 120
- Pages
- 88-104
- ISSN
- 0197-4580 (ISSN-L)
- OpenAlex
- W4294193270
- Cited by
- 78
- References
- 74
- FWCI
- 7.96
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.